AI Revolution: Digital Biology with insitro's Daphne Koller

a16z Live

Innhold levert av a16z and Andreessen Horowitz. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av a16z and Andreessen Horowitz eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

1y ago 22:28

MP3•Episoder hjem

Daphne Koller is the founder and CEO of insitro, a company using AI and machine learning to engineer drug discovery. In this conversation with a16z's Vijay Pande, she discusses how an LLM for cells could revolutionize drug discovery and how to bridge the technological and cultural divide between building with atoms and building with bits.

[0:59] Why life sciences?
[3:42] AI in the life sciences
[7:20] LLM for cells
[11:55] Engineering disease and drug discovery
[13:51] Bits vs. atoms
[17:55] The opportunity ahead

This conversation is part of our AI Revolution series, recorded August 2023 at a live event in San Francisco. The series features some of the most impactful builders in the field of AI discussing and debating where we are, where we’re going, and the big open questions in AI. Find more content from our AI Revolution series on www.a16z.com/AIRevolution.

137 episoder

#Entrepreneur #Business #Andreessen Horowitz #Disruption #Culture #Innovation #Tech #Podcasting Education #A16z #software Eats The World